BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37737158)

  • 1. Evaluation of factors associated with survival in allogeneic stem cell-transplanted patients admitted to the intensive care unit (ICU).
    Serries M; Zenzen H; Heine M; Holderried T; Brossart P; Schwab K
    Hematology; 2023 Dec; 28(1):2256198. PubMed ID: 37737158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential Organ Failure Assessment Score and the Need for Organ Support Predict Mortality in Allogeneic Stem Cell Transplant Patients Admitted to the Intensive Care Unit.
    Díaz-Lagares C; Fox L; García-Roche A; Santafe M; Romera I; Barba P; Pacheco A; Roldán E; Plata-Menchaca E; Roca O; Pérez M; Valcarcel D; Ferrer R
    Transplant Cell Ther; 2021 Oct; 27(10):865.e1-865.e7. PubMed ID: 34217846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and Long-Term Survival of Adolescent and Young Adult Patients Admitted to the Intensive Care Unit Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience of 152 Patients.
    Solaiman OM; Elhassan T; Fakih RE; Mannan A; Alduhailib Z; Mahdali AA; Alzahrani H; Jamil M; Chaudhri N; Elhazmi A; Kolko M; Al-Sharif FZ; Alrbiaan A; Shaban M; Shaheen M; Salahuddin N; Alfraih FA; Altarifi AS; Hassanein M; Hosaini S; Alhashim N; Mohamed AA; Hanbali A; Aljanoubi AH; Al-Obaidi NR; Rasheed W; Maghrabi K; Almohareb F; Soubani A; Aljurf M; Ahmed SO
    Hematol Oncol Stem Cell Ther; 2024 Mar; 17(2):110-119. PubMed ID: 38560973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of Allogeneic Haematopoietic Stem Cell Recipients Admitted to the Intensive Care Unit: A Retrospective, Single-Centre Study.
    Lindgaard SC; Nielsen J; Lindmark A; Sengeløv H
    Acta Haematol; 2016; 135(2):72-8. PubMed ID: 26512978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning.
    Townsend WM; Holroyd A; Pearce R; Mackinnon S; Naik P; Goldstone AH; Linch DC; Peggs KS; Thomson KJ; Singer M; Howell DC; Morris EC
    Br J Haematol; 2013 May; 161(4):578-86. PubMed ID: 23496350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: Outcomes of patients admitted to intensive care unit.
    Mokart D; Granata A; Crocchiolo R; Sannini A; Chow-Chine L; Brun JP; Bisbal M; Faucher M; Faucher C; Blache JL; Castagna L; Fürst S; Blaise D
    J Crit Care; 2015 Oct; 30(5):1107-13. PubMed ID: 26193780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes-results of a retrospective analysis from a German university hospital.
    Garcia Borrega J; Heger JM; Koehler P; Holtick U; Hallek M; Scheid C; Böll B; Shimabukuro-Vornhagen A; Kochanek M; Eichenauer DA
    Ann Hematol; 2022 Feb; 101(2):389-395. PubMed ID: 34668981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overall Survival Rate in Allogeneic Stem Cell Transplanted Patients Requiring Intensive Care Can Be Predicted by the Prognostic Index for Critically Ill Allogeneic Transplantation Patients (PICAT) and the Sequential Organ Failure Assessment (SOFA) Scores.
    De Voeght A; Willems E; Servais S; Seidel L; Pirotte M; Massion P; Layios N; Pereira M; Misset B; Canivet JL; Beguin Y; Baron F
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077800
    [No Abstract]   [Full Text] [Related]  

  • 9. Feasibility of Cyclosporine Prophylaxis Withdrawal in Critically Ill Allogenic Hematopoietic Stem Cell Transplant Patients Admitted to the Intensive Care Unit With No GVHD.
    Saillard C; Legal PH; Furst S; Bisbal M; Servan L; Sannini A; Gonzalez F; Faucher M; Vey N; Blaise D; Chow-Chine L; Mokart D
    Transplant Cell Ther; 2022 Nov; 28(11):783.e1-783.e10. PubMed ID: 35964937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor?
    Wu PH; Huo WX; Mo XD; Wang Y; Yan CH; Jiang H; Shen MZ; Huang XJ; An YZ
    Ann Hematol; 2023 Apr; 102(4):907-916. PubMed ID: 36757444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors and outcome of adult allogeneic hematopoietic stem cell transplantation patients admitted to intensive care unit during transplant hospitalization.
    Michel CS; Teschner D; Schmidtmann I; Theobald M; Hauptrock B; Wagner-Drouet EM; Radsak MP
    Sci Rep; 2019 Dec; 9(1):19911. PubMed ID: 31882648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections in hematopoietic stem cell transplant patients admitted to Hematology intensive care unit: a single-center study.
    Barlas T; İnci K; Aygencel G; Türkoğlu M; Tunçcan ÖG; Can F; Aydın Kaynar L; Özkurt ZN; Yeğin ZA; Yağcı M
    Hematology; 2021 Dec; 26(1):328-339. PubMed ID: 33818297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Index for Critically Ill Allogeneic Transplantation Patients.
    Bayraktar UD; Milton DR; Shpall EJ; Rondon G; Price KJ; Champlin RE; Nates JL
    Biol Blood Marrow Transplant; 2017 Jun; 23(6):991-996. PubMed ID: 28263919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intensive care management process in patients with hematopoietic stem cell transplantation and factors affecting their prognosis.
    Boyacı N; Aygencel G; Turkoglu M; Yegin ZA; Acar K; Sucak GT
    Hematology; 2014 Sep; 19(6):338-45. PubMed ID: 24620953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children.
    Schneider DT; Lemburg P; Sprock I; Heying R; Göbel U; Nürnberger W
    Bone Marrow Transplant; 2000 May; 25(10):1079-86. PubMed ID: 10828869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports.
    Pène F; Aubron C; Azoulay E; Blot F; Thiéry G; Raynard B; Schlemmer B; Nitenberg G; Buzyn A; Arnaud P; Socié G; Mira JP
    J Clin Oncol; 2006 Feb; 24(4):643-9. PubMed ID: 16380411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year mortality of hematopoietic stem cell recipients admitted to an intensive care unit in a dedicated Brazilian cancer center: a retrospective cohort study.
    Archanjo LVF; Caruso P; Nassar Junior AP
    Sao Paulo Med J; 2022; 141(2):107-113. PubMed ID: 35920534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients.
    Afessa B; Tefferi A; Dunn WF; Litzow MR; Peters SG
    Crit Care Med; 2003 Jun; 31(6):1715-21. PubMed ID: 12794410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009-2013).
    Platon L; Amigues L; Ceballos P; Fegueux N; Daubin D; Besnard N; Larcher R; Landreau L; Agostini C; Machado S; Jonquet O; Klouche K
    Bone Marrow Transplant; 2016 Feb; 51(2):256-61. PubMed ID: 26569092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Factors and Intensive Care Outcome in Post-Transplant Phase of Hematopoietic Stem Cell Transplantation: Intensive Care Outcome in Hematopoietic Stem Cell Transplantation.
    Mutlu YG; Aydin BB; Erdogan C; Kizilaslan D; Beköz HS; Gemici A; Kaynar L; Sevindik ÖG
    Indian J Hematol Blood Transfus; 2023 Apr; 39(2):167-172. PubMed ID: 37006979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.